Pharmaceutical business group urges overhaul of drug pricing policy

Published: 2008-03-18 06:57:00

Updated: 2008-03-18 06:57:00

The Korea Pharmaceutical Manufacturers Association has urged a new minister of Health, Welfare and Family Affairs to ameliorate the current drug pricing policy, the so-called positive list system, under which only medicines with proven efficacy and price-competitiveness will be covered by health ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK